Annual Cash & Cash Equivalents
$47.48 M
+$8.53 M+21.91%
31 December 2023
Summary:
RAPT Therapeutics annual cash & cash equivalents is currently $47.48 million, with the most recent change of +$8.53 million (+21.91%) on 31 December 2023. During the last 3 years, it has risen by +$22.56 million (+90.54%). RAPT annual cash & cash equivalents is now -38.65% below its all-time high of $77.38 million, reached on 31 December 2019.RAPT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$37.90 M
+$823.00 K+2.22%
30 September 2024
Summary:
RAPT Therapeutics quarterly cash and cash equivalents is currently $37.90 million, with the most recent change of +$823.00 thousand (+2.22%) on 30 September 2024. Over the past year, it has dropped by -$16.23 million (-29.99%). RAPT quarterly cash and cash equivalents is now -58.59% below its all-time high of $91.53 million, reached on 31 March 2020.RAPT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.9% | -30.0% |
| 3 y3 years | +90.5% | -36.8% |
| 5 y5 years | -25.6% | -21.6% |
RAPT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +97.6% | -36.8% | +57.7% |
| 5 y | 5 years | -38.6% | +97.6% | -58.6% | +87.3% |
| alltime | all time | -38.6% | >+9999.0% | -58.6% | +87.3% |
RAPT Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $37.90 M(+2.2%) |
| June 2024 | - | $37.08 M(-18.2%) |
| Mar 2024 | - | $45.32 M(-4.6%) |
| Dec 2023 | $47.48 M(+21.9%) | $47.48 M(-12.3%) |
| Sept 2023 | - | $54.13 M(+7.9%) |
| June 2023 | - | $50.16 M(+9.6%) |
| Mar 2023 | - | $45.77 M(+17.5%) |
| Dec 2022 | $38.95 M(+62.1%) | $38.95 M(+40.6%) |
| Sept 2022 | - | $27.71 M(-51.6%) |
| June 2022 | - | $57.20 M(+76.5%) |
| Mar 2022 | - | $32.42 M(+34.9%) |
| Dec 2021 | $24.03 M(-3.6%) | $24.03 M(-60.0%) |
| Sept 2021 | - | $60.00 M(-30.4%) |
| June 2021 | - | $86.22 M(+248.8%) |
| Mar 2021 | - | $24.72 M(-0.8%) |
| Dec 2020 | $24.92 M | $24.92 M(+23.2%) |
| Sept 2020 | - | $20.23 M(-30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $28.96 M(-68.4%) |
| Mar 2020 | - | $91.53 M(+18.3%) |
| Dec 2019 | $77.38 M(+21.3%) | $77.38 M(+60.2%) |
| Sept 2019 | - | $48.31 M(-19.3%) |
| June 2019 | - | $59.86 M(-3.1%) |
| Mar 2019 | - | $61.76 M(-3.2%) |
| Dec 2018 | $63.80 M(+34.3%) | $63.80 M |
| Dec 2017 | $47.52 M(>+9900.0%) | - |
| Aug 2013 | $140.30 K(+581.1%) | - |
| Aug 2012 | $20.60 K(-97.3%) | - |
| Aug 2011 | $772.10 K(+262.3%) | - |
| Aug 2010 | $213.10 K(-10.6%) | - |
| Aug 2009 | $238.40 K(+1679.1%) | - |
| Aug 2008 | $13.40 K(-80.7%) | - |
| Aug 2007 | $69.60 K(-21.8%) | - |
| Aug 2006 | $89.00 K(-70.8%) | - |
| Aug 2005 | $305.20 K(+2834.6%) | - |
| Aug 2004 | $10.40 K | - |
FAQ
- What is RAPT Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RAPT Therapeutics?
- What is RAPT Therapeutics annual cash & cash equivalents year-on-year change?
- What is RAPT Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly cash and cash equivalents year-on-year change?
What is RAPT Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of RAPT is $47.48 M
What is the all time high annual cash & cash equivalents for RAPT Therapeutics?
RAPT Therapeutics all-time high annual cash & cash equivalents is $77.38 M
What is RAPT Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, RAPT annual cash & cash equivalents has changed by +$8.53 M (+21.91%)
What is RAPT Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RAPT is $37.90 M
What is the all time high quarterly cash and cash equivalents for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly cash and cash equivalents is $91.53 M
What is RAPT Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, RAPT quarterly cash and cash equivalents has changed by -$16.23 M (-29.99%)